BCB
Brian C. Broderick Portfolio holdings
AUM
$506M
This Quarter Return
+9.92%
1 Year Return
+12.39%
3 Year Return
+70.69%
5 Year Return
+110.99%
10 Year Return
+270.67%
AUM
$401M
AUM Growth
+$401M
(+10%)
Cap. Flow
+$5.22M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
41.72%
Holding
79
New
–
Increased
42
Reduced
12
Closed
4
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$602K |
| 2 |
Microsoft
MSFT
|
$442K |
| 3 |
Abbott
ABT
|
$428K |
| 4 |
Xylem
XYL
|
$422K |
| 5 |
UnitedHealth
UNH
|
$375K |
Top Sells
| 1 |
Illumina
ILMN
|
$1.78M |
| 2 |
PayPal
PYPL
|
$1.05M |
| 3 |
Danaher
DHR
|
$1.02M |
| 4 |
Honeywell
HON
|
$730K |
| 5 |
CVS Health
CVS
|
$717K |
Sector Composition
| 1 | Technology | 30.26% |
| 2 | Healthcare | 18.29% |
| 3 | Industrials | 12.27% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Consumer Staples | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$203B
| $3.77M | 0.94% |
22,192
-368
| -2% | -$62.5K |
|
27
Exxon Mobil
XOM
$477B
| $3.73M | 0.93% |
37,347
+2,050
| +6% | +$205K |
|
|
28
Honeywell
HON
$136B
| $3.24M | 0.81% |
15,437
-3,483
| -18% | -$730K |
|
|
29
CVS Health
CVS
$93B
| $3.01M | 0.75% |
38,089
-9,084
| -19% | -$717K |
|
30
Novartis
NVS
$248B
| $2.82M | 0.7% |
27,960
-1,055
| -4% | -$107K |
|
31
Medtronic
MDT
$118B
| $2.75M | 0.69% |
33,408
-225
| -0.7% | -$18.5K |
|
32
Church & Dwight Co
CHD
$22.7B
| $2.72M | 0.68% |
28,800
| – | – |
|
33
Aptiv
APTV
$17.3B
| $1.94M | 0.48% |
21,596
+1,390
| +7% | +$125K |
|
34
AbbVie
ABBV
$374B
| $1.7M | 0.42% |
10,939
-1,258
| -10% | -$195K |
|
35
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11B
| $1.7M | 0.42% |
29,000
| – | – |
|
36
Airbnb
ABNB
$76.5B
| $1.54M | 0.38% |
11,294
+1,576
| +16% | +$215K |
|
37
Adobe
ADBE
$148B
| $1.2M | 0.3% |
2,012
+12
| +0.6% | +$7.16K |
|
38
HubSpot
HUBS
$24.9B
| $1.16M | 0.29% |
2,000
| – | – |
|
39
Becton Dickinson
BDX
$54.3B
| $1.11M | 0.28% |
4,555
+515
| +13% | +$126K |
|
40
CrowdStrike
CRWD
$104B
| $1.03M | 0.26% |
4,015
+15
| +0.4% | +$3.83K |
|
41
Trane Technologies
TT
$90.9B
| $955K | 0.24% |
3,915
| – | – |
|
42
Moderna
MRNA
$9.36B
| $955K | 0.24% |
9,600
| – | – |
|
43
Pembina Pipeline
PBA
$21.9B
| $899K | 0.22% |
26,124
+3,800
| +17% | +$131K |
|
44
Merck
MRK
$210B
| $831K | 0.21% |
7,625
+1,500
| +24% | +$164K |
|
45
Novo Nordisk
NVO
$252B
| $794K | 0.2% |
7,680
-450
| -6% | -$46.6K |
|
46
Intel
INTC
$105B
| $789K | 0.2% |
15,710
+3,000
| +24% | +$151K |
|
47
Edwards Lifesciences
EW
$47.7B
| $767K | 0.19% |
10,053
-927
| -8% | -$70.7K |
|
48
Union Pacific
UNP
$132B
| $700K | 0.17% |
2,851
+1,130
| +66% | +$278K |
|
49
Bristol-Myers Squibb
BMY
$96.7B
| $605K | 0.15% |
11,800
+100
| +0.9% | +$5.13K |
|
50
Thermo Fisher Scientific
TMO
$183B
| $520K | 0.13% |
980
| – | – |
|